Home
Saturn V Capital Management reported a 5.2% stake in Monopar Therapeutics MNPR · 345,626 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 5.2%
- Last report
- First report
- Shares held
- 345,626 sh
- Class
- Common Stock
- Event date
- 26/01/05
- Filed
- 26/05/15
First 5%+ report · 5.2% stake
Monopar Therapeutics trades, last 26 weeks
What else happened in Monopar Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/06~02/04Saturn V Capital Management's other 5% stake reports
- Saturn V Capital Management
5% stakeMonopar Therapeutics
5% stakeMonopar Therapeutics
MNPR
4.7% stake
313,384 sh
4.7% stake
Filed 08/12
- Saturn V Capital Management
5% stakeImmix Biopharma
5% stakeImmix Biopharma
IMMX
6.97% stake
3,693,585 sh
6.97% stake
Filed 02/17
- Saturn V Capital Management
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
7.36% stake
6,433,481 sh
7.36% stake
Filed 02/17
